Evidence map›Paper›PMID 27791019›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Central role for melanocortin-4 receptors in offspring hypertension arising from maternal obesity.

Anne-Maj S Samuelsson, Amandine Mullier, Nuria Maicas, Nynke R Oosterhuis, Sung Eun Bae, Tatiana V Novoselova, Li F Chan, Joaquim M Pombo, Paul D Taylor, Jaap A Joles and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Neonatal hyperoxia exposure does not exacerbate hypertension programmed by maternal obesity.American journal of physiology. Regulatory, integrative and comparative physiology · 2026
    Article
  9. Review
  10. Review
  11. Guidelines for in vivo models of developmental programming of cardiovascular disease risk.American journal of physiology. Heart and circulatory physiology · 2024
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Anomalous AMPK-regulated angiotensin ATJournal of biomedical science · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Anne-Maj S SamuelssonDivision of Women's Health, King's College London, Women's Health Academic Centre King's Health Partners, London SE1 7EH, United Kingdom; anne-maj.samuelsson@kcl.ac.uk.
Amandine MullierDivision of Women's Health, King's College London, Women's Health Academic Centre King's Health Partners, London SE1 7EH, United Kingdom.
Nuria MaicasDivision of Women's Health, King's College London, Women's Health Academic Centre King's Health Partners, London SE1 7EH, United Kingdom.
Nynke R OosterhuisDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht 3584 CX, The Netherlands.
Sung Eun BaeDivision of Women's Health, King's College London, Women's Health Academic Centre King's Health Partners, London SE1 7EH, United Kingdom.
Tatiana V NovoselovaWilliam Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London EC1M, United Kingdom.
Li F ChanWilliam Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London EC1M, United Kingdom.
Joaquim M PomboDivision of Women's Health, King's College London, Women's Health Academic Centre King's Health Partners, London SE1 7EH, United Kingdom.
Paul D TaylorDivision of Women's Health, King's College London, Women's Health Academic Centre King's Health Partners, London SE1 7EH, United Kingdom.
Jaap A JolesDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht 3584 CX, The Netherlands.
Clive W CoenDivision of Women's Health, King's College London, Women's Health Academic Centre King's Health Partners, London SE1 7EH, United Kingdom.
Nina BalthasarSchool of Physiology and Pharmacology, University of Bristol, Bristol BS8 1TH, United Kingdom.
Lucilla PostonDivision of Women's Health, King's College London, Women's Health Academic Centre King's Health Partners, London SE1 7EH, United Kingdom.
King's College London · GBKings Health Partners · GBUniversity Medical Center Utrecht · NLQueen Mary University of London · GBUniversity of Bristol · GBWilliam Harvey Research Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BBD5231861Biotechnology and Biological Sciences Research Council BB/H008845/1British Heart Foundation FS/09/057/27957British Heart Foundation FS/10/003/28163Medical Research Council G0802796
6 · The paper itself

Abstract

Melanocortin-4 receptor (Mc4r)-expressing neurons in the autonomic nervous system, particularly in the paraventricular nucleus of the hypothalamus (PVH), play an essential role in blood pressure (BP) control. Mc4r-deficient (Mc4rKO) mice are severely obese but lack obesity-related hypertension; they also show a reduced pressor response to salt loading. We have previously reported that lean juvenile offspring born to diet-induced obese rats (OffOb) exhibit sympathetic-mediated hypertension, and we proposed a role for postnatally raised leptin in its etiology. Here, we test the hypothesis that neonatal hyperleptinemia due to maternal obesity induces persistent changes in the central melanocortin system, thereby contributing to offspring hypertension. Working on the OffOb paradigm in both sexes and using transgenic technology to restore Mc4r in the PVH of Mc4rKO (Mc4rPVH) mice, we have now shown that these mice develop higher BP than Mc4rKO or WT mice. We have also found that experimental hyperleptinemia induced in the neonatal period in Mc4rPVH and WT mice, but not in the Mc4rKO mice, leads to heightened BP and severe renal dysfunction. Thus, Mc4r in the PVH appears to be required for early-life programming of hypertension arising from either maternal obesity or neonatal hyperleptinemia. Early-life exposure of the PVH to maternal obesity through postnatal elevation of leptin may have long-term consequences for cardiovascular health.

Indexed as

AnimalsBlood PressureDietDisease Models, AnimalFemaleHumansHypertensionLeptinMaleMaternal-Fetal RelationsMice, KnockoutNeuronsObesityParaventricular Hypothalamic NucleusPregnancyPrenatal Exposure Delayed EffectsLeptinReceptor, Melanocortin, Type 4developmental programminghypertensionmaternal obesitymelanocortin-4 receptorssympathetic nerve activity

Identifiers

PMID27791019
PMCPMC5087049
OpenAlexW2529427282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.